Pharmaceutical patents: incentives for R&D or marketing?
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
Bergen
Norwegian School of Economics and Business Administration
2005
|
| Schriftenreihe: | Discussion paper / Norwegian School of Economics and Business Administration
2005,22 |
| Schlagworte: | |
| Beschreibung: | 36 S. graph. Darst. |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV024609578 | ||
| 003 | DE-604 | ||
| 005 | 20090910 | ||
| 007 | t | ||
| 008 | 090924s2005 d||| |||| 00||| eng d | ||
| 035 | |a (OCoLC)916635991 | ||
| 035 | |a (DE-599)BVBBV024609578 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-83 | ||
| 100 | 1 | |a Brekke, Kurt R. |e Verfasser |0 (DE-588)124603238 |4 aut | |
| 245 | 1 | 0 | |a Pharmaceutical patents |b incentives for R&D or marketing? |c by Kurt R. Brekke ; Odd Rune Straume |
| 264 | 1 | |a Bergen |b Norwegian School of Economics and Business Administration |c 2005 | |
| 300 | |a 36 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Discussion paper / Norwegian School of Economics and Business Administration |v 2005,22 | |
| 650 | 0 | 7 | |a Forschung und Entwicklung |0 (DE-588)4017897-3 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittel |0 (DE-588)4003115-9 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Produktmarketing |0 (DE-588)4134049-8 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Arzneimittel |0 (DE-588)4003115-9 |D s |
| 689 | 0 | 1 | |a Forschung und Entwicklung |0 (DE-588)4017897-3 |D s |
| 689 | 0 | 2 | |a Produktmarketing |0 (DE-588)4134049-8 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Straume, Odd Rune |d 1971- |e Verfasser |0 (DE-588)123875846 |4 aut | |
| 810 | 2 | |a Norwegian School of Economics and Business Administration |t Discussion paper |v 2005,22 |w (DE-604)BV002799935 |9 2005,22 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-018582389 | ||
Datensatz im Suchindex
| _version_ | 1804140626025906176 |
|---|---|
| any_adam_object | |
| author | Brekke, Kurt R. Straume, Odd Rune 1971- |
| author_GND | (DE-588)124603238 (DE-588)123875846 |
| author_facet | Brekke, Kurt R. Straume, Odd Rune 1971- |
| author_role | aut aut |
| author_sort | Brekke, Kurt R. |
| author_variant | k r b kr krb o r s or ors |
| building | Verbundindex |
| bvnumber | BV024609578 |
| ctrlnum | (OCoLC)916635991 (DE-599)BVBBV024609578 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01469nam a2200361 cb4500</leader><controlfield tag="001">BV024609578</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20090910 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">090924s2005 d||| |||| 00||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)916635991</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV024609578</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-83</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Brekke, Kurt R.</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)124603238</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Pharmaceutical patents</subfield><subfield code="b">incentives for R&D or marketing?</subfield><subfield code="c">by Kurt R. Brekke ; Odd Rune Straume</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Bergen</subfield><subfield code="b">Norwegian School of Economics and Business Administration</subfield><subfield code="c">2005</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">36 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Discussion paper / Norwegian School of Economics and Business Administration</subfield><subfield code="v">2005,22</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Forschung und Entwicklung</subfield><subfield code="0">(DE-588)4017897-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Produktmarketing</subfield><subfield code="0">(DE-588)4134049-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Forschung und Entwicklung</subfield><subfield code="0">(DE-588)4017897-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Produktmarketing</subfield><subfield code="0">(DE-588)4134049-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Straume, Odd Rune</subfield><subfield code="d">1971-</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)123875846</subfield><subfield code="4">aut</subfield></datafield><datafield tag="810" ind1="2" ind2=" "><subfield code="a">Norwegian School of Economics and Business Administration</subfield><subfield code="t">Discussion paper</subfield><subfield code="v">2005,22</subfield><subfield code="w">(DE-604)BV002799935</subfield><subfield code="9">2005,22</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-018582389</subfield></datafield></record></collection> |
| id | DE-604.BV024609578 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T22:02:58Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-018582389 |
| oclc_num | 916635991 |
| open_access_boolean | |
| owner | DE-83 |
| owner_facet | DE-83 |
| physical | 36 S. graph. Darst. |
| publishDate | 2005 |
| publishDateSearch | 2005 |
| publishDateSort | 2005 |
| publisher | Norwegian School of Economics and Business Administration |
| record_format | marc |
| series2 | Discussion paper / Norwegian School of Economics and Business Administration |
| spelling | Brekke, Kurt R. Verfasser (DE-588)124603238 aut Pharmaceutical patents incentives for R&D or marketing? by Kurt R. Brekke ; Odd Rune Straume Bergen Norwegian School of Economics and Business Administration 2005 36 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier Discussion paper / Norwegian School of Economics and Business Administration 2005,22 Forschung und Entwicklung (DE-588)4017897-3 gnd rswk-swf Arzneimittel (DE-588)4003115-9 gnd rswk-swf Produktmarketing (DE-588)4134049-8 gnd rswk-swf Arzneimittel (DE-588)4003115-9 s Forschung und Entwicklung (DE-588)4017897-3 s Produktmarketing (DE-588)4134049-8 s DE-604 Straume, Odd Rune 1971- Verfasser (DE-588)123875846 aut Norwegian School of Economics and Business Administration Discussion paper 2005,22 (DE-604)BV002799935 2005,22 |
| spellingShingle | Brekke, Kurt R. Straume, Odd Rune 1971- Pharmaceutical patents incentives for R&D or marketing? Forschung und Entwicklung (DE-588)4017897-3 gnd Arzneimittel (DE-588)4003115-9 gnd Produktmarketing (DE-588)4134049-8 gnd |
| subject_GND | (DE-588)4017897-3 (DE-588)4003115-9 (DE-588)4134049-8 |
| title | Pharmaceutical patents incentives for R&D or marketing? |
| title_auth | Pharmaceutical patents incentives for R&D or marketing? |
| title_exact_search | Pharmaceutical patents incentives for R&D or marketing? |
| title_full | Pharmaceutical patents incentives for R&D or marketing? by Kurt R. Brekke ; Odd Rune Straume |
| title_fullStr | Pharmaceutical patents incentives for R&D or marketing? by Kurt R. Brekke ; Odd Rune Straume |
| title_full_unstemmed | Pharmaceutical patents incentives for R&D or marketing? by Kurt R. Brekke ; Odd Rune Straume |
| title_short | Pharmaceutical patents |
| title_sort | pharmaceutical patents incentives for r d or marketing |
| title_sub | incentives for R&D or marketing? |
| topic | Forschung und Entwicklung (DE-588)4017897-3 gnd Arzneimittel (DE-588)4003115-9 gnd Produktmarketing (DE-588)4134049-8 gnd |
| topic_facet | Forschung und Entwicklung Arzneimittel Produktmarketing |
| volume_link | (DE-604)BV002799935 |
| work_keys_str_mv | AT brekkekurtr pharmaceuticalpatentsincentivesforrdormarketing AT straumeoddrune pharmaceuticalpatentsincentivesforrdormarketing |